# EDGAR Filing Document

**Accession Number:** 0002020332
**File Stem:** 0002020332-26-000003
**Filing Date:** 2026-4
**Character Count:** 2958
**Document Hash:** 2243eddfb46527bfcb800b43a020c1b6
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0002020332-26-000003.hdr.sgml**: 20260424

**ACCESSION NUMBER**: 0002020332-26-000003

**CONFORMED SUBMISSION TYPE**: C-AR

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20251231

**FILED AS OF DATE**: 20260424

**DATE AS OF CHANGE**: 20260424

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** 32 Biosciences, Inc.
- **CENTRAL INDEX KEY:** 0002020332

**ORGANIZATION NAME:**
- **EIN:** 931732754
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** C-AR
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 020-34357
- **FILM NUMBER:** 26891200

**BUSINESS ADDRESS:**
- **STREET 1:** 3333 GREEN BAY RD
- **STREET 2:** SUITE 210
- **CITY:** ILLINOIS
- **STATE:** IL
- **ZIP:** 60064
- **BUSINESS PHONE:** 18479225332

**MAIL ADDRESS:**
- **STREET 1:** 3333 GREEN BAY RD
- **STREET 2:** SUITE 210
- **CITY:** ILLINOIS
- **STATE:** IL
- **ZIP:** 60064

### Attached PDF Documents

**Attachment 1:** `biosciences.pdf`

_No text found in this document._

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM C

### UNDER THE SECURITIES ACT OF 1933

### Issuer Information

**Name of Issuer:** 32 Biosciences, Inc.

**Legal Status:** Corporation

**Jurisdiction of Incorporation/Organization:** DE

**Date of Organization:** 06-05-2023

**Physical Address:** 3333 GREEN BAY RD, ILLINOIS, IL, 60064

**Issuer Website:** https://32biosciences.com/

**Is there a Co-Issuer?:** No

### Annual Report Disclosure Requirements

**Current Number of Employees:** 7.00

**Total Assets (Most Recent Fiscal Year):** $2,091,486.00

**Total Assets (Prior Fiscal Year):** $1,478,698.00

**Cash & Cash Equivalents (Most Recent Fiscal Year):** $1,857,311.00

**Cash & Cash Equivalents (Prior Fiscal Year):** $1,183,699.00

**Accounts Receivable (Most Recent Fiscal Year):** $0.00

**Accounts Receivable (Prior Fiscal Year):** $0.00

**Short-Term Debt (Most Recent Fiscal Year):** $358,681.00

**Short-Term Debt (Prior Fiscal Year):** $14,917.00

**Long-Term Debt (Most Recent Fiscal Year):** $5,378,215.00

**Long-Term Debt (Prior Fiscal Year):** $3,177,281.00

**Revenues/Sales (Most Recent Fiscal Year):** $0.00

**Revenues/Sales (Prior Fiscal Year):** $53,691.00

**Cost of Goods Sold (Most Recent Fiscal Year):** $0.00

**Cost of Goods Sold (Prior Fiscal Year):** $0.00

**Taxes Paid (Most Recent Fiscal Year):** $0.00

**Taxes Paid (Prior Fiscal Year):** $0.00

**Net Income (Most Recent Fiscal Year):** $-3,091,429.00

**Net Income (Prior Fiscal Year):** $-1,742,797.00

### Signatures

**Issuer:** 32 Biosciences, Inc.

**Signature:** Peter Farmakis

**Title:** Chief Executive Officer

---

**Signature:** Peter Farmakis

**Title:** Chairman

**Date:** 04-24-2026

---

**Signature:** Jayson Slotnik

**Title:** Director

**Date:** 04-24-2026

---

**Signature:** Franklin R. Cockerill III

**Title:** Director

**Date:** 04-24-2026